For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well

works

How RINVOQ

Know the science—that's power

RINVOQ is a once-daily pill that treats adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well. RINVOQ works with your body to fight the inflammation that can lead to UC symptoms.

The amount of inflammation you have is controlled by many different proteins that are found naturally within your body. RINVOQ stops the activity of some of those proteins, known as Janus kinase (JAK), to help reduce inflammation.

Because JAK inhibitors, including RINVOQ, affect the immune system, they can lower the ability to fight infections and may cause other serious side effects. It’s important to talk to your healthcare provider about the possible side effects of prescription treatments. Learn more about side effects.

Jasmine's Story

My doctor had put me on a couple of steroid drugs and injections, and unfortunately they did not work for me.

—JASMINE, moderate to severe UC patient

Interested in learning more about RINVOQ?

People living with UC achieved RINVOQ Results >


Take charge: More topics for you

Meet real RINVOQ patients

Find out what patients have to say about their experience with UC and RINVOQ.

Think beyond symptom relief

Focus on long-term goals such as steroid-free remission and colon lining repair—and what these could mean for you.